Chad Yuhasz - Dec 9, 2024 Form 4 Insider Report for Gatos Silver, Inc. (GATO)

Signature
/s/ Stephen Bodley as Attorney-in-fact for Chad Yuhasz
Stock symbol
GATO
Transactions as of
Dec 9, 2024
Transactions value $
$0
Form type
4
Date filed
12/11/2024, 06:15 PM
Previous filing
Apr 24, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GATO Employee Stock Option (Right to Buy) Award $0 +15.6K $0.00 15.6K Dec 9, 2024 Common Stock 15.6K $15.34 Direct F1
transaction GATO Restricted Stock Units Award $0 +9.19K $0.00 9.19K Dec 9, 2024 Common Stock 9.19K Direct F2, F3
holding GATO Restricted Stock Units 27.5K Dec 9, 2024 Common Stock 27.5K Direct F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options were granted on December 9, 2024. These options shall vest in three equal tranches on each of December 9, 2025, December 9, 2026 and December 9, 2027.
F2 Each restricted share unit ("RSUs") represents a contingent right to receive one share of the issuer's common stock, an equivalent amount of cash, or a combination thereof upon vesting.
F3 The RSUs will vest on December 9, 2027.
F4 On April 15, 2024, the reporting person was granted a total of 27,500 RSUs, which vest on December 31, 2026. Such RSUs were previously reported in Table I of Form 4 by the reporting person. See Remarks below for additional information.

Remarks:

Effective December 9, 2024, the issuer and the reporting person executed an amendment to the RSUs previously granted to the reporting person whereby the reporting person's outstanding RSUs may, in addition to being settled in shares of the issuer common stock, be settled in an equivalent amount of cash, or a combination of cash and shares. Accordingly, beginning with this Form 4, the reporting person's outstanding RSUs that were previously reported in Table I of Form 4 as common stock equivalents are now reported in Table II of Form 4 as derivative securities.